Structure |
Chemical Name |
CAS |
MF |
|
Topiroxostat Impurity 6 |
|
|
|
Irinotecan EP Impurity H |
|
|
|
Teneligliptin Impurity 4 |
|
|
|
Erlotinib Hydrochloride iMpurity 53 |
|
|
|
(3R,4S)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylate |
2389152-22-9 |
C26H24FNO5 |
|
Moxifloxacin EP Impurity K |
|
|
|
Anestagnate |
|
|
|
Canagliflozin Monoacetyl Impurity |
|
|
|
Etoricoxib Impurity 13 |
1817735-82-2 |
C25H20ClN3O3S |
|
Mirabegron Impurity 11 |
1684452-85-4 |
C21H24N4O2S |
|
2-Propenamide, 2-cyano-3-(3,4-dihydroxyphenyl)-N,N-diethyl-, (2E)- |
1217439-96-7 |
C14H16N2O3 |
|
Riociguat Impurtiy 2 |
|
|
|
Topiroxostat Impurity 9 |
577778-82-6 |
C13H8N6O |
|
Benzonitrile, 4,4'-[[2,2'-bis(hydroxymethyl)[1,1'-biphenyl]-4,4'-diyl]bis(oxy)]bis- |
2254541-79-0 |
C28H20N2O4 |
|
Vonoprazan Impurity F |
|
|
|
Benzoic acid, 3-(butylamino)-5-[(butylamino)sulfonyl]-4-phenoxy- |
28469-01-4 |
C21H28N2O5S |
|
Vortioxetine Impurity 15 |
2099147-02-9 |
C28H34N4S2 |
|
Dapagliflozin Impurity H |
|
|
|
Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]- |
298197-26-9 |
C13 H17 N5 O6 |
|
Topiroxostat Impurity 46 |
|
|
|
Topiroxostat Impurity 43 |
|
|
|
N-(2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)-N-methyl formamide |
1643948-40-6 |
C17H25NO3 |
|
Regorafenib Impurity 40 |
|
|
|
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester |
2489671-14-7 |
C17H18FNO5 |
|
Bisoprolol Impurity 17 |
109791-19-7 |
C15H23NO5 |
|
Furosemide Impurity 5 |
518336-22-6 |
C12H10ClNO3 |
|
Lumateperone Impurity 2 |
313544-32-0 |
C16H19N3O3 |
|
Pramipexole Impurity 55 |
959012-83-0 |
C8H11NO2 |
|
INDEX NAME NOT YET ASSIGNED |
2438857-80-6 |
C27H22F2N6O5 |
|
Nicergoline Impurity 01 |
|
|
|
impurity 38 |
|
|
|
Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-bromophenoxy]- |
2227126-09-0 |
C16H12BrNO3 |
|
3-Pyridineacrylonitrile, α-(m-chlorophenyl)-β-hydroxy- (8CI) |
18206-80-9 |
C14H9ClN2O |
|
Androsta-3,16-dien-17-ol, acetate, (5α)- (9CI) |
103088-58-0 |
C21H30O2 |
|
1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1S,4S)- |
91797-61-4 |
C17H19N |
|
2-Pyridineethanamine, N-methyl-N-nitroso- |
32635-81-7 |
C8H11N3O |
|
Peramivir Impurity 45 |
|
|
|
Pentanamide, 5-(diphenylphosphinyl)-N-ethyl- |
2512198-63-7 |
C19H24NO2P |
|
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,6b,9,10,10a-hexahydro-, ethyl ester, (6bR,10aS)- |
313369-17-4 |
C16H21N3O2 |
|
Dapoxetine Impurity C |
|
|
|
Iodixanol Impurity |
|
|
|
Levothyroxine EP Impurity B |
1628720-66-0 |
C15H11ClI3NO4 |
|
Ribavirin Imp. EP) |
|
|
|
Sertraline EP Impurity |
|
C17H17Cl2N |
|
Vildagliptin Related Compound G |
1616662-84-0 |
C12H20N4O3 |
|
3-ethyl 5-isopropyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate |
158151-92-9 |
C22H29ClN2O5 |
|
Methyl 3-acetamido-4-(2,4,5-trifluorophenyl)but-2-enoate |
1234321-81-3 |
C13H12F3NO3 |
|
FG-4592 intermediate 8 |
1509958-20-6 |
C20H17NO6 |
|
Parecoxib Sodium Imp.E |
|
|
|
Trelagliptin Impurity 7 |
|
|
|
Pramipexole impurity II |
|
|
|
tert-butyl 4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate |
1651214-74-2 |
C29H37N7O4 |
|
Prasugrel Impurity 4 HCl |
1618107-96-2 |
C20H22Cl2FNO3S |
|
Tofacitinib Impurity K |
|
|
|
Cefmetazole impurity |
56796-19-1 |
C28H27N7O5S3 |
|
3-ethylisobenzofuran-1(3H)-one |
17475-41-1 |
C10H10O2 |
|
Ivabradine Impurity 21 HCl |
304465-03-0 |
C26H34N2O5 |
|
Moxifloxacin EP Impurity C HCl |
|
|
|
Moxifloxacin Impurity 23 |
855661-74-4 |
C21H24FN3O4 |
|
Solifenacin Related Compound 18 |
1225338-27-1 |
C23H26N2O2 |
|
N-(2-hydroxy-3-(4-((2-isopropoxyethoxy)methyl)phenoxy)propyl) -N-isopropylformamide |
1447715-45-8 |
C19H31NO5 |
|
Tofacitinib Related Compound |
1206824-85-2 |
C10H18ClN3O |
|
Fluvastatin EP impurity A -G |
93957-58-5 |
C24H26FNO4 |
|
PWKRNMKZGWGSDV-UHFFFAOYSA-N |
1422960-88-0 |
C33H34ClN4+ |
|
sodium:(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoate |
1329502-92-2 |
C33H41N4NaO7 |
|
QFJAHHNMKTWTGZ-DZAPPIOQSA-N |
2045402-27-3 |
C35H36ClNO4S |
|
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-5,6,7,8-tetrahydro-1-naphthalenecarboxamide |
1374226-74-0 |
C18H24N2O |
|
BJQMFFOQQWEWAF-DGBYXFBUSA-N |
1709825-83-1 |
C31H41ClO8 |
|
(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
|
C23H29FN6O4S |
|
(5-Ethyl-1H-imidazol-4-yl)methanol |
38603-74-6 |
C6H10N2O |
|
(Z)-1-(6-methylpyridin-3-yl)-2-(4-(methylsulfonyl)phenyl)ethanone oxime |
1810761-43-3 |
C15H16N2O3S |
|
ethylidene phthalide |
61658-90-0 |
C10H8O2 |
|
6-amino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl) -7-methyl-7,9-dihydro-8H-purin-8-one |
1361569-18-7 |
C19H15FN8O |
|
3-トリフルオロメチル-5-(P-トリル)-1H-ピラゾール |
219986-64-8 |
C11H9F3N2 |
|
5-メチル-3-フェニルイソオキサゾール-4-カルボン酸 |
1136-45-4 |
C11H9NO3 |
|
Bendamustine Impurity 26 |
|
|
|
Canagliflozin Impurity 26 |
|
|
|
Edoxaban Impurity 37 |
2081883-50-1 |
C14H27N3O3 |
|
Imatinib Impurity 10 |
|
|
|
Levofloxacin Impurity 19 |
|
C18H20FN3O4 |
|
Olanzapine Impurity K |
|
C17H20N4S |
|
Ticagrelor Related Compound 55 |
|
|
|
Ticagrelor Related Compound 73 |
|
|
|
Vildagliptin Impurity 10 |
|
|
|
Cefaclor Impurity 2 |
722547-49-1 |
C17H18N2O3 |
|
Cefodizime Impurity F |
|
|
|
Olaparib Impurity F |
|
|
|
Ornidazole Impurity G |
|
|
|
Pidotimod Impurity L |
|
|
|
Tadalafil Impuirty 20 |
2924098-58-6 |
|
|
Tenofovir Impurity 53 |
|
|
|
Ergoline-8-methanol, 10-hydroxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8β)- |
57935-66-7 |
C23H24BrN3O3 |
|
(5S,6S,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4- thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid 5-oxide |
|
|
|
Ethanone, 2-chloro-1-[3-nitro-4-(phenylmethoxy)phenyl]- |
871266-45-4 |
C15H12ClNO4 |
|
Cisatracurium besylate impurity11 |
|
|
|
(3R,5S,E)-tert-butyl 7-(4-(2-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate |
|
|
|
Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?- |
2575516-61-7 |
C16H16N2O4 |
|
Ganciclovir EP Impurity |
|
|
|
Crisaborole Impurity 15 |
|
|
|
Latamoxef impurity A |
|
|